These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12127537)

  • 1. Design and synthesis of novel inhibitors of gelatinase B.
    Wang X; Choe Y; Craik CS; Ellman JA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2201-4. PubMed ID: 12127537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro and in silico NS5B polymerase inhibitory activity of benzimidazole derivatives.
    Patil VM; R GK; Chudayeu M; Gupta SP; Samanta S; Masand N; Kaushik-Basu N
    Med Chem; 2012 Jul; 8(4):629-35. PubMed ID: 22530910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
    Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives.
    Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W
    Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid phase combinatorial synthesis of 1,2,5-trisubstituted benzimidazole derivatives as human DHODH inhibitors.
    Sitwala ND; Vyas VK; Variya BC; Patel SS; Mehta CC; Rana DN; Ghate MD
    Bioorg Chem; 2017 Dec; 75():118-126. PubMed ID: 28941392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead.
    Moriarty KJ; Winters M; Qiao L; Ryan D; DesJarlis R; Robinson D; Cook BN; Kashem MA; Kaplita PV; Liu LH; Farrell TM; Khine HH; King J; Pullen SS; Roth GP; Magolda R; Takahashi H
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5537-40. PubMed ID: 18819794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
    Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
    J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
    Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
    Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, p38 kinase inhibitory and anti-inflammatory activity of new substituted benzimidazole derivatives.
    Kulkarni RG; Laufer SA; M CV; Garlapati A
    Med Chem; 2013 Feb; 9(1):91-9. PubMed ID: 22946527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on conventional and microwave synthesis of some benzimidazole, benzothiazole and indole derivatives and testing on inhibition of hyaluronidase.
    Algul O; Kaessler A; Apcin Y; Yilmaz A; Jose J
    Molecules; 2008 Mar; 13(4):736-48. PubMed ID: 18463575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
    Sahoo PK; Behera P
    Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
    Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
    Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
    Saitoh M; Kunitomo J; Kimura E; Hayase Y; Kobayashi H; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GS; Snell GP; Itoh F
    Bioorg Med Chem; 2009 Mar; 17(5):2017-29. PubMed ID: 19200745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole and benzimidazole derivatives as steroid 5alpha-reductase inhibitors in the rat prostate.
    Takami H; Kishibayashi N; Ishii A; Kumazawa T
    Bioorg Med Chem; 1998 Dec; 6(12):2441-8. PubMed ID: 9925300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).
    Yu Y; Wu Z; Shi ZC; He S; Lai Z; Cernak TA; Vachal P; Liu M; Liu J; Hong Q; Jian T; Guiadeen D; Krikorian A; Sperbeck DM; Verras A; Sonatore LM; Murphy BA; Wiltsie J; Chung CC; Gorski JN; Liu J; Xiao J; Wolff M; Tong SX; Madeira M; Karanam BV; Shen DM; Balkovec JM; De Vita RJ; Pinto S; Nargund RP
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1380-1385. PubMed ID: 30952592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the helicase activity of the HCV NS3 protein by symmetrical dimeric bis-benzimidazoles.
    Tunitskaya VL; Mukovnya AV; Ivanov AA; Gromyko AV; Ivanov AV; Streltsov SA; Zhuze AL; Kochetkov SN
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5331-5. PubMed ID: 21821416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.
    Augé F; Hornebeck W; Decarme M; Laronze JY
    Bioorg Med Chem Lett; 2003 May; 13(10):1783-6. PubMed ID: 12729664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors.
    Skalitzky DJ; Marakovits JT; Maegley KA; Ekker A; Yu XH; Hostomsky Z; Webber SE; Eastman BW; Almassy R; Li J; Curtin NJ; Newell DR; Calvert AH; Griffin RJ; Golding BT
    J Med Chem; 2003 Jan; 46(2):210-3. PubMed ID: 12519059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors.
    Wang J; Wang X; Li H; Ji D; Li Y; Xu Y; Zhu Q
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4127-32. PubMed ID: 27353531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa).
    Brink M; Dahlén A; Olsson T; Polla M; Svensson T
    Bioorg Med Chem; 2014 Apr; 22(7):2261-8. PubMed ID: 24588961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.